GHA
CMD

GW Henssler & Associates’s Cantel Medical Corporation CMD Stock Holding History

GW Henssler & Associates’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,523
Closed -$521K – 275
2021
Q1 		$521K Sell
6,523
-1,500
-19% -$117K 0.04% 118
2020
Q4 		$633K Sell
8,023
-533
-6% -$31.3K 0.05% 101
2020
Q3 		$376K Buy
+8,556
New +$422K 0.03% 131

GW Henssler & Associates's CMD Position: Q2 2021 in Review

GW Henssler & Associates sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 6,523 shares — an estimated $521K sold.

GW Henssler & Associates first reported a position in CMD in Q3 2020 and held it in 3 quarters. The position peaked at $633K in Q4 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • GW Henssler & Associates reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • GW Henssler & Associates sold 6,523 Cantel Medical Corporation shares in Q2 2021, an estimated $521K.
  • GW Henssler & Associates first reported a position in Cantel Medical Corporation in Q3 2020 and held it in 3 quarters.
  • GW Henssler & Associates's Cantel Medical Corporation position peaked at $633K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on GW Henssler & Associates's 13F filing for Q2 2021, filed 9 Aug 2021.